← Alle mensen

LM

Luis Matamala

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Nivolumab plus relatlimab in gevorderd melanoma: RELATIVITY-047 4-year update.

European journal of cancer (Oxford, England : 1990) · 25 juli 2025

Three-Year Totale overleving With Nivolumab Plus Relatlimab in Gevorderd Melanoma From RELATIVITY-047.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025-05

Relatlimab plus nivolumab versus nivolumab bij onbehandeld gevorderd melanoom: RELATIVITY-047 fase II/III

The New England journal of medicine · 6 januari 2022